Indonesia has data centers, copper and tin, and not one listed chip designer, memory maker, network supplier or AI platform — eight of the eleven layers have no IDX representative at all, which means the local AI trade is a bet on being a landlord and a supplier, not a builder, and the most expensive stock on the exchange is priced on 2,000 MW it has not built rather than the 128 MW it actually runs.
Companion post to [The AI Stack: Why Where a Stock Sits Matters More Than Whether It Says "AI"]. September 2026. Run the eleven layers of the AI supply chain against the Indonesia Stock Exchange and something uncomfortable shows up immediately. There is no Indonesian chip designer. No memory manufacturer. No optical networking company. No foundation model. No enterprise AI plat…
Indonesia punya data center, tembaga, dan timah, tetapi tidak punya satu pun emiten perancang chip, produsen memori, pemasok jaringan, atau platform AI — delapan dari sebelas lapisan tidak memiliki perwakilan di BEI sama sekali. Artinya, taruhan AI lokal adalah taruhan menjadi tuan tanah dan pemasok, bukan pembangun, dan saham termahal di bursa dihargai berdasarkan 2.000 MW yang belum dibangun, bukan 128 MW yang benar-benar beroperasi.
Artikel pendamping untuk [The AI Stack: Why Where a Stock Sits Matters More Than Whether It Says "AI"]. September 2026. · Coba jalankan sebelas lapisan rantai pasok AI ke Bursa Efek Indonesia, dan satu hal yang tidak nyaman langsung terlihat. Tidak ada perancang chip Indonesia. Tidak ada produsen memori. Tidak ada perusahaan optical networking. Tidak ada foundation model. Tidak…
Eleven layers of the AI supply chain, 104 listed names, and one pattern that keeps repeating: the companies with capacity already contracted into 2027 and 2028 are consistently not the ones getting the loudest coverage — and several of the loudest have no revenue at all.
Index post for an 11-part series. September 2026. Two companies both describe themselves as AI plays. One has a $163 billion order backlog stretching years into the future. The other has no revenue and a story about what happens in 2030. Both go up when the AI narrative is hot. Only one of them is still standing when it isn't. That difference has almost nothing to do with how m…
Everyone is piling into AI stocks. Meanwhile, one of the world's biggest casino companies has fallen to its lowest price in a year — even though its resorts are still full and it is buying back a huge slice of its own shares. Here's why Las Vegas Sands deserves a second look.
In 2026, almost every conversation about the stock market comes back to one thing: artificial intelligence. Chips, data centers, chatbots. If a company can't spell "AI," investors seem to lose interest. That is exactly why Las Vegas Sands (NYSE: LVS) is interesting. This is a business you can touch. People get on planes, walk into a resort, eat, watch a show, and yes — gamble.…
● 3 updates — View →
Latest update · Sep 15, 2026
Verdict: The story got safer. The price didn't move much yet.
TPIA is a record-earning, fundamentally transformed company trading at a five-year low — and the next twenty days, specifically the MSCI review on June 23, will determine whether this is the buying opportunity of 2026 or the beginning of something much more serious for Indonesia's stock market.
Indonesia’s largest petrochemical company just reported the best quarter in its history. Its stock is near a five-year low. And the next three weeks could decide everything. If you’ve been watching PT Chandra Asri Pacific (TPIA) this week, you’ve seen one of the most dramatic two-day reversals on the Jakarta exchange in recent memory. On Tuesday, June 2, the stock surged 12% to…
● 2 updates — View →
Latest update · Sep 15, 2026
Current price: $28.81. The revenue story is real. The profit story is not. We're taking 4% and walking away — here's everything that happened in three months.
Hims & Hers is an incredibly resilient, cash-rich digital health leader that the market has fundamentally mispriced at under 2.0x forward revenues due to a short-sighted overreaction to temporary GLP-1 compounding regulations.
Turning Regulatory Turbulence into an Asymmetric Buying Opportunity: The Case for Hims & Hers Health The world of growth investing rarely offers second chances. When a hyper-growth company experiences a sharp 60% drawdown from its market highs, the investing community often reacts with panic rather than analytical curiosity. This is exactly what is happening with Hims & Hers He…